Ono Pharmaceutical saw the highest growth of 1.82% in patent filings in June and 1.74% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.52% and grants by 0.66%. GlobalData’s DataBook provides a comprehensive analysis of Ono Pharmaceutical‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Ono Pharmaceutical has been focused on protecting inventions in United States(US) with 15 publications in Q2 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 37% filings and 21% grants. The United States(US), Hungary(HU), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Ono Pharmaceutical is filings its patents. Among the top granted patent authorities, Ono Pharmaceutical has 21% of its grants in United States(US), 17% in Australia(AU) and 12% in Japan(JP).

Roche and Johnson & Johnson could be the strongest competitors for Ono Pharmaceutical

Patents related to rare diseases and climate change lead Ono Pharmaceutical's portfolio

Ono Pharmaceutical has the highest number of patents in rare diseases followed by, climate change and addiction. For rare diseases, nearly 67% of patents were filed and 62% of patents were granted in Q2 2024.

Mobiles, hand-helds, pdas, smartphones related patents lead Ono Pharmaceutical portfolio followed by tenosynovial giant cell tumor, and pancreatic cancer

Ono Pharmaceutical has highest number of patents in mobiles, hand-helds, pdas, smartphones followed by tenosynovial giant cell tumor, pancreatic cancer, gastrointestinal stromal tumor (gist), and glioma. For mobiles, hand-helds, pdas, smartphones, nearly 3% of patents were filed and 2% of patents were granted in Q2 2024.

For comprehensive analysis of Ono Pharmaceutical's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.